Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Heterogeneous_FDG-guided_dose-escalation_for_locally_advanced_NSCLC_2017_accepted
Accepted author manuscript, 180 KB, PDF document
Original language | English |
---|---|
Journal | Radiotherapy & Oncology |
Volume | 124 |
Issue number | 2 |
Pages (from-to) | 311-317 |
ISSN | 0167-8140 |
DOIs | |
Publication status | Published - Aug 2017 |
- NSCLC, Dose-escalation, Randomized phase-III trial
Research areas
Number of downloads are based on statistics from Google Scholar and www.ku.dk
No data available
ID: 184386819